When to Prescribe Combined Oral Contraceptives vs. Norethisterone
Combined oral contraceptives (COCs) should be prescribed when contraception is required in healthy women without cardiovascular risk factors, while norethisterone alone (progestin-only) is indicated when estrogen is contraindicated due to cardiovascular risk factors, breastfeeding, or specific medical conditions. 1
Primary Decision Framework: Contraceptive Need and Risk Assessment
When COCs Are First-Line Choice
For contraception in low-risk women:
- Women under 35 years without cardiovascular risk factors can use COCs regardless of smoking status 1
- Type 1 diabetics without complications (no nephropathy, advanced retinopathy, cardiovascular disease, or neuropathy) and no additional risk factors (dyslipidemia, hypertension, smoking, diabetes >20 years) 1
- Women requiring both contraception and hormone replacement (e.g., premature ovarian insufficiency): 17β-estradiol-based COCs are first choice, with ethinylestradiol-based COCs as second choice 2
- Adolescents and young women seeking contraception: monophasic pills with 30-35 μg ethinylestradiol combined with levonorgestrel or norgestimate are recommended starting formulations 3
Preferred COC formulations for safety:
- Levonorgestrel or norethisterone combined with ethinylestradiol ≤35 μg are considered first-line due to lowest venous thromboembolism risk 4, 5
- These formulations have equivalent thromboembolic safety profiles 6
When Norethisterone (Progestin-Only) Is Indicated
Absolute indications for norethisterone over COCs:
Cardiovascular contraindications:
Diabetic patients:
Breastfeeding:
Hormone replacement without contraceptive need:
- When withdrawal bleeding is acceptable: transdermal 17β-estradiol with oral/vaginal progestin (norethisterone 1 mg daily minimum for continuous regimens, or 10 mg for 12-14 days/month for sequential regimens) 2
- Norethisterone is listed as second choice among progestins (after micronized progesterone, before MPA and dydrogesterone) 2
Special Clinical Scenarios
Short-term menstrual delay:
- Norethisterone 5 mg three times daily is superior to COCs when started late in cycle (on or before cycle day 12) 9
- Results in significantly less breakthrough bleeding (8% vs 43% with COCs) 9
- Particularly useful when even minimal breakthrough bleeding cannot be tolerated 9
Primary dysmenorrhea:
- Continuous norethisterone acetate 5 mg daily is as effective as cyclical COCs (drospirenone/ethinylestradiol) 10
- More cost-effective and requires less analgesic use 10
Critical Safety Considerations
COC contraindications requiring norethisterone alternative:
- Combined contraception is formally contraindicated in women with personal history of arterial events; non-hormonal methods should be preferred, with progestin-only methods discussed by multidisciplinary panel 1
- The contraindication applies to all routes of combined hormonal administration (oral, transdermal, vaginal) 1
Norethisterone-specific warnings:
- Does not protect against STDs; barrier methods must be used concurrently if at risk 8
- Increased ectopic pregnancy risk (5 per 1000 woman-years) compared to COCs 8
- Must be taken at same time daily; backup contraception needed for 48 hours if >3 hours late 8
- Irregular bleeding is common and not harmful 8
Common pitfall: Blood pressure measurement is the only mandatory clinical investigation before prescribing COCs 1. Failure to check blood pressure before COC prescription represents a critical safety oversight.